Clinical trials
Phase 2/3 Tuberculosis, Pulmonary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medecins Sans Frontieres, Netherlands | 3 |
| Centers for Disease Control and Prevention | 1 |
| Global Alliance for TB Drug Development | 1 |
| Huashan Hospital | 1 |
| Obafemi Awolowo University Teaching Hospital | 1 |
| Orient Pharma Co., Ltd. | 1 |
| University College, London | 1 |
| University of California, San Francisco | 1 |
| University of Cape Town | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Pulmonary | 11 |
| Tuberculosis, Multidrug-Resistant | 5 |
| Tuberculosis | 4 |
| Extensively Drug-Resistant Tuberculosis | 3 |
| Inflammation | 1 |
| Latent Tuberculosis | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
Trials
Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.